24/7 Emergency & General Advisory
🚨 24/7 Medical Emergency
Non-Emergency Advisory
10:00 AM – 6:00 PM, Mon–Sat
For appointments & general queries.
Join our healthcare community
Wild poliovirus remains endemic in only two countries — Afghanistan and Pakistan — and 2026 case counts are running well below last year's total, according to WHO surveillance data. But progress is fragile: a major funding shortfall, vaccination bans in parts of Afghanistan, and ongoing vaccine-deri
Wild poliovirus remains endemic in only two countries in the world: Afghanistan and Pakistan. As of early August 2026, the World Health Organization has confirmed 18 wild poliovirus cases globally this year — 15 in Afghanistan and three in Pakistan — down sharply from 52 cases across both countries for all of 2025. Eradication has not been achieved, but the trajectory is improving even as funding and access challenges threaten to slow it.
WHO's Eastern Mediterranean Polio Bulletin, covering the week ending August 2, 2026, put Afghanistan's case total at 15 for the year — the highest of any country globally in 2026 — with Pakistan's total at three. That combined figure of 18 compares favorably to the same period in recent years: 2025 ended with 52 cases (21 in Afghanistan, 31 in Pakistan), and 2024 ended with 94 cases globally.
Environmental surveillance, which tests sewage for signs of the virus even where no one has been diagnosed, tells a similar story. Afghanistan has recorded 34 positive environmental samples in 2026, and Pakistan 90 — both down from 2025 levels, when Afghanistan logged 94 and Pakistan 651.
[REVIEWER: add clinical insight here — for example, why environmental surveillance is considered an early warning signal distinct from confirmed clinical cases]
Not all polio cases come from the same source, and the distinction matters for how outbreaks are managed. Wild poliovirus type 1 (WPV1) is the naturally occurring virus that has circulated in Afghanistan and Pakistan for decades. It's the strain the global eradication campaign was originally built around, and it's now down to two remaining reservoirs.
Circulating vaccine-derived poliovirus type 2 (cVDPV2) is different. It can emerge in under-vaccinated communities when the weakened virus used in the oral polio vaccine mutates and regains the ability to spread and cause paralysis. cVDPV2 outbreaks have occurred in more than a dozen countries in recent years, primarily where routine immunization coverage is low. WHO's original eradication strategy targeted 2026 for certifying WPV1 eradication, but the timeline has since been extended: the goal is now to certify WPV1 eradication by the end of 2027 and stop cVDPV2 transmission by the end of 2029.
Two forces are working against faster progress. The first is access. In parts of Afghanistan, authorities have restricted house-to-house vaccination campaigns, which public health officials say leaves children unreached and creates pockets of vulnerability even as overall case numbers fall.
The second is money. The Global Polio Eradication Initiative, the WHO-led coalition running the eradication campaign, is facing a 30% budget reduction in 2026 and a funding gap estimated at $1.7 billion through 2029. Officials have said publicly that the shortfall means some planned activities simply won't happen. Reduced contributions from several major donor countries are cited as the main driver.
[REVIEWER: add clinical insight here — for example, how reduced surveillance funding specifically affects the ability to detect silent transmission before it causes paralysis]
Despite the setbacks, WHO officials maintain that eradication remains within reach. Two of the three original wild poliovirus strains — types 2 and 3 — have already been declared eradicated, in 2015 and 2019 respectively. The WHO African Region was certified free of wild poliovirus in 2020, following the South-East Asia Region in 2014.
What remains is a narrowing problem: a small number of persistent transmission zones, concentrated in southern Afghanistan and parts of Khyber Pakhtunkhwa in Pakistan, rather than widespread circulation. New tools are also part of the strategy — WHO recently prequalified an additional novel oral polio vaccine (nOPV2) manufacturer, expanding global supply for outbreak response.
Two vaccines work together in the current strategy. The inactivated polio vaccine (IPV) is an injected vaccine used in routine immunization schedules in most countries, including the United States, and provides strong individual protection against all three poliovirus types. The novel oral polio vaccine type 2 (nOPV2) is used specifically to respond to and stop community transmission during cVDPV2 outbreaks, and was designed to be more genetically stable than the original oral vaccine it replaces in outbreak settings.
Where is wild polio still active in 2026? Wild poliovirus remains endemic only in Afghanistan and Pakistan. As of early August 2026, WHO has confirmed 18 cases globally this year, down from 52 for all of 2025, though transmission continues in a small number of persistent reservoirs.
What's the difference between wild polio and vaccine-derived polio? Wild poliovirus circulates naturally and is now confined to two countries. Vaccine-derived poliovirus can emerge when the weakened virus in oral vaccines mutates in under-immunized communities, and it has caused outbreaks in over a dozen countries in recent years.
When is polio expected to be eradicated? WHO's Global Polio Eradication Initiative now targets certifying wild poliovirus eradication by the end of 2027, with vaccine-derived poliovirus elimination targeted for the end of 2029 — both later than the original 2026 goal.
Why hasn't polio been eradicated yet if cases are so low? Access restrictions in parts of Afghanistan and a significant funding shortfall for the global eradication campaign have slowed progress, even as case counts fall. Officials say the remaining transmission chains require sustained, well-funded vaccination campaigns to fully interrupt.
Is the polio vaccine still needed if wild polio is so rare? Yes. Routine immunization with IPV remains standard practice worldwide, both to protect individuals and to prevent immunity gaps that allow vaccine-derived outbreaks to take hold in under-vaccinated communities.
Polio eradication is closer than it's ever been — two of three viral strains are gone, and 2026 case counts are running well below recent years — but the finish line has moved twice now, and funding and access remain the deciding factors. For most readers, the relevant action is simple: keep routine polio vaccination current for children, since population-level immunity is what ultimately closes the door on both wild and vaccine-derived transmission.
This article is for general education and does not provide medical diagnosis or treatment guidance. Anyone with questions about vaccination should consult a qualified healthcare provider.
World Health Organization, Eastern Mediterranean Polio Bulletin (week ending August 2, 2026)
World Health Organization, "Statement of the Forty-fourth Meeting of the Polio IHR Emergency Committee" (March 2026)
World Health Organization, "Polio Eradication Strategy 2022–2026: Delivering on a Promise, Extension to 2029"
World Health Organization, "WHO Prequalifies an Additional Novel Oral Polio Vaccine" (February 2026)
CDC, "About Global Polio Eradication" — cdc.gov/globa
Visit Hospital
Near You
Not sure if your child's fever needs a doctor visit? Learn the warning signs, home-care tips, and how to book the best doctor for child fever in Deoghar.
August 14, 2026
Looking for the best doctors for Child Imperforate Anus Low Anomaly Perineal Anoplasty in Deoghar? Compare pediatric anorectal malformation surgery costs, consultation fees, hospital details, patient reviews, treatment options, recovery information, and expert care for congenital colorectal disorder
June 6, 2026
Looking for the best doctors for Child Congenital Pyloric Stenosis Operation in Deoghar? Compare pediatric pyloromyotomy surgery costs, consultation fees, hospital details, patient reviews, treatment options, recovery information, and expert care for congenital pyloric stenosis and neonatal gastroin
June 6, 2026